Dr Agarwals Health Care Ltd
Dr Agarwals Health Care Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Growth expected to sustain at a similar pace as FY '26, driven by deeper penetration of existing micro markets and expansion into new geographies. Expectation of sustaining growth pace similar to FY '26, underpinned by: - Deeper penetration in existing micro markets - Expansion into new geographies including strong focus on North India (Delh
From Dr Agarwals Health Care Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Growth expected to sustain at a similar pace as FY '26, driven by deeper penetration of existing micro markets and expansion into new geographies. (Page 7, 8)
- Accelerated adoption of innovative surgical procedures and advanced technologies to enhance service offerings. (Page 7, 8)
- FY '27 facility addition plan includes commissioning 60 new facilities (40 surgical centers, 20 clinics), mostly organic growth. (Page 17, 18)
- North region (including Delhi NCR) expected to see highest ever addition of 16 facilities, with rapid build-out in micro markets including Noida, Ghaziabad, and key towns in Haryana. (Page 7)
- Mumbai region to be a key focus area for aggressive scaling in FY '27 due to strong traction of recent facilities. (Page 6)
- Refractive surgeries expected to grow long term, supported by potential insurance partnerships and premiumization of procedures. (Page 18)
2 more points management made on revenue & sales performance
Profitability & Margins
See what Dr Agarwals Health Care Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- For FY '27, Dr. Agarwal's Healthcare Limited plans a total capex of approximately INR 380 to 400 crores.
- This includes the addition of 60 new facilities: 40 surgical centers and 20 clinics.
- Capex also covers the establishment of a new CMS (Centralized Medical Services) facility.
- The new CMS facility expected to commission by October 1, 2026, pending approvals.
- Acquisition-related payments for FY '27 are expected to be around INR 60-65 crores.
- The company focuses on organic growth but remains open to partnerships if aligned strategically and financially.
2 more points management made on capital expenditure plans
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Dr Agarwals Health Care Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- For acquisition-related payments pending post FY '26:
- FY '27 expected payout: ~INR 65 crores
- FY '28, '29, and small payments in '30 combined: ~INR 60-66 crores
- No specific mention of a traditional "order book" as the company operates in healthcare services, not manufacturing.
- The company is focused on organic growth with plans to open 40 surgical centers and 20 clinics in FY '27.
- They continue to explore partnerships if aligned and reasonably priced, but these are not included in the current pipeline.
2 more points management made on order book & pipeline
Dr Agarwals Health Care Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹564 Cr, net profit ₹50 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Dr Agarwal's Hea's management said in earlier quarters
Others in Healthcare Services this season
- KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
- Gaudium IVF (Q4 FY26)
Revenue growth seen in FY26: INR 104.35 crore, a 47.56% increase from FY25. Key concall takeaways from Gaudium IVF's Q4 FY26 earnings call — and how it ranks…
- Apollo Hospitals Enterprise Ltd (Q4 FY26)
30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…
Frequently Asked Questions
What were Dr Agarwals Health Care Ltd Q4 FY26 results?
Growth expected to sustain at a similar pace as FY '26, driven by deeper penetration of existing micro markets and expansion into new geographies. Expectation of sustaining growth pace similar to FY '26, underpinned by: - Deeper penetration in existing micro markets - Expansion into new geographies including strong focus on North India (Delh
What is Dr Agarwals Health Care Ltd share price analysis?
Dr Agarwals Health Care Ltd currently shows a neutral. The stock trades at a P/E of 111.9 with a market cap of ₹16,519 Cr. Investors should review the full earnings analysis for detailed insights.
Is Dr Agarwals Health Care Ltd planning capital expenditure?
For FY '27, Dr.
Keep Dr Agarwals Health Care Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.